Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹16 Cr₹11 Cr₹11 Cr₹-0.68 Cr₹3.63 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of VENUS REMEDIES ?

The latest Deferred Tax Assets / Liabilities ratio of VENUS REMEDIES is ₹16 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹16 Cr
Mar2024₹11 Cr
Mar2023₹11 Cr
Mar2022₹-0.68 Cr
Mar2021₹3.63 Cr

How is Deferred Tax Assets / Liabilities of VENUS REMEDIES Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹16 Cr
42.73
Mar2024 ₹11 Cr
2.54
Mar2023 ₹11 Cr
Positive
Mar2022 ₹-0.68 Cr
Negative
Mar2021 ₹3.63 Cr -

Compare Deferred Tax Assets / Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹606.9 Cr -2.4% -0.3% 36.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,862.0 Cr 0.9% 3.7% -13.5% Stock Analytics
DIVIS LABORATORIES ₹174,125.0 Cr 7.4% 9% 8.2% Stock Analytics
CIPLA ₹125,454.0 Cr 3.3% 0.2% -7.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,106.0 Cr -0.7% -1.7% -0.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,263.0 Cr 1% -3.2% -5.2% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-2.4%

-0.3%

36.1%

SENSEX

0.1%

0.6%

0.7%


You may also like the below Video Courses